Decay-accelerating Factor (DAF), Complement Receptor 1 (CR1), and Factor H Dissociate the Complement AP C3 Convertase (C3bBb) via Sites on the Type A Domain of Bb
Open Access
- 1 January 2002
- journal article
- Published by Elsevier
- Vol. 277 (2), 1107-1112
- https://doi.org/10.1074/jbc.m109322200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Structure/function studies of human decay‐accelerating factorImmunology, 2000
- The role of complement in the acquired immune responseImmunology, 2000
- Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: A solution study by circular dichroism, fourier transform infrared and 1H NMR spectroscopyJournal of Molecular Biology, 2000
- Identification of the c3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor BJournal of Molecular Biology, 1999
- Anatomy of hot spots in protein interfacesJournal of Molecular Biology, 1998
- Molecular modeling and mechanism of action of human decay-accelerating factorProtein Engineering, Design and Selection, 1996
- Women Fight Uphill Battle for EquityScience, 1996
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- Inhibition of NF-κB activation by a dominant-negative mutant of IκBαMolecular Immunology, 1996
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993